BIOMAT Database Logo BIOMAT Database Logo

[Clinical evaluation of penfluridol--a neuroleptic with prolonged action (oral administration) in the treatment of schizophrenic psychoses]. 1978

A Majczak, and M Wielosz, and A Grzywa, and L Kornacki, and J Nagay, and M Jasińska

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010395 Penfluridol One of the long-acting ANTIPSYCHOTIC AGENTS used for maintenance or long-term therapy of SCHIZOPHRENIA and other PSYCHOTIC DISORDERS. R-16341,Semap,R 16341,R16341
D010880 Piperidines A family of hexahydropyridines.
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

A Majczak, and M Wielosz, and A Grzywa, and L Kornacki, and J Nagay, and M Jasińska
[Clinical evaluation of a weekly maintenance neuroleptic: penfluridol (R16341)].
December 1976, Acta psiquiatrica y psicologica de America latina,
A Majczak, and M Wielosz, and A Grzywa, and L Kornacki, and J Nagay, and M Jasińska
Anticonvulsants as adjuncts for the neuroleptic treatment of schizophrenic psychoses: a clinical study with beclamide.
February 1990, Acta psychiatrica Scandinavica,
A Majczak, and M Wielosz, and A Grzywa, and L Kornacki, and J Nagay, and M Jasińska
[Clinical experiences with an oral, long-term neuroleptic agent: penfluridol].
April 1973, Die Medizinische Welt,
A Majczak, and M Wielosz, and A Grzywa, and L Kornacki, and J Nagay, and M Jasińska
[Pentazole-neuroleptic and neuroleptic treatment of acute schizophrenic psychoses in a catamnestic comparison].
January 1961, Psychiatria et neurologia,
A Majczak, and M Wielosz, and A Grzywa, and L Kornacki, and J Nagay, and M Jasińska
[Differential neuroleptic treatment of schizophrenic psychoses in puerperium: advantages of the atypical neuroleptic clozapine].
July 1992, Der Nervenarzt,
A Majczak, and M Wielosz, and A Grzywa, and L Kornacki, and J Nagay, and M Jasińska
Penfluridol, a peroral long-acting neuroleptic, for the maintenance treatment of schizophrenic patients who relapse.
April 1977, Journal of clinical pharmacology,
A Majczak, and M Wielosz, and A Grzywa, and L Kornacki, and J Nagay, and M Jasińska
[Duration of clinical treatment & its success in schizophrenic psychoses; comparison of neuroleptic therapy with older treatment procedures].
August 1958, Der Nervenarzt,
A Majczak, and M Wielosz, and A Grzywa, and L Kornacki, and J Nagay, and M Jasińska
[Long-term treatment of schizophrenic psychoses using retard-neuroleptic preparations].
April 1972, Die Medizinische Welt,
A Majczak, and M Wielosz, and A Grzywa, and L Kornacki, and J Nagay, and M Jasińska
[Prolonged treatment of schizophrenic psychoses with depot-fluphenazine ("lyogen decanoate")].
January 1968, Neuropsihijatrija,
A Majczak, and M Wielosz, and A Grzywa, and L Kornacki, and J Nagay, and M Jasińska
[Initial clinical response to neuroleptic treatment and serum prolactin levels in acute schizophrenic psychoses].
January 1981, Actas luso-espanolas de neurologia, psiquiatria y ciencias afines,
Copied contents to your clipboard!